24 Aug 2023

In 1H23, Vincent Medical’s (VM) sales increased by 28.7% YoY to HK$361.2m. GPM jumped from 13.1% to 32.9% in 1H23, representing an impressive YoY improvement of 19.8ppt. This was mainly due to the decrease in allowance for inventories, improvement in operating efficiency and the depreciation of Rmb. Driven by encouraging topline growth, coupled with clear GPM enhancement, VM’s bottom line turned from a loss of HK$44.4m to a NP of HK$26.6m.

CROSBY Research – Vincent Medical (1612 HK/BUY): Staging a turnaround in 1H23